These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 24126273)

  • 1. Estimating the comparative clinical and economic consequences of tulathromycin for treatment of present or anticipated outbreaks of bovine respiratory disease in feedlot cattle in the United States.
    Nautrup BP; Van Vlaenderen I; Gasper SM; Holland RE
    J Anim Sci; 2013 Dec; 91(12):5868-77. PubMed ID: 24126273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of tulathromycin compared with tilmicosin and florfenicol for the control of respiratory disease in cattle at high risk of developing bovine respiratory disease.
    Rooney KA; Nutsch RG; Skogerboe TL; Weigel DJ; Gajewski K; Kilgore WR
    Vet Ther; 2005; 6(2):154-66. PubMed ID: 16094563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of tulathromycin versus florfenicol and tilmicosin against undifferentiated bovine respiratory disease in feedlot cattle.
    Skogerboe TL; Rooney KA; Nutsch RG; Weigel DJ; Gajewski K; Kilgore WR
    Vet Ther; 2005; 6(2):180-96. PubMed ID: 16094565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of tilmicosin versus tulathromycin as a metaphylactic antimicrobial in feedlot calves at moderate risk for respiratory disease.
    Van Donkersgoed J; Merrill J; Hendrick S
    Vet Ther; 2008; 9(4):291-7. PubMed ID: 19177334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of florfenicol and tulathromycine for the treatment of undifferentiated fever in feedlot calves.
    Perrett T; Abutarbush SM; Wildman BK; Fuchs MT; Schunicht OC; Pollock CM; Fenton RK; Jim GK; Guichon PT; Booker CW; Berg J; Roder J; Spire M
    Vet Ther; 2008; 9(2):128-40. PubMed ID: 18597251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of tulathromycin and tilmicosin on the prevalence and severity of bovine respiratory disease in feedlot cattle in association with feedlot performance, carcass characteristics, and economic factors.
    Tennant TC; Ives SE; Harper LB; Renter DG; Lawrence TE
    J Anim Sci; 2014 Nov; 92(11):5203-13. PubMed ID: 25349362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of tulathromycin, tilmicosin, and florfenicol in the treatment of bovine respiratory disease in stocker cattle.
    Nutsch RG; Skogerboe TL; Rooney KA; Weigel DJ; Gajewski K; Lechtenberg KF
    Vet Ther; 2005; 6(2):167-79. PubMed ID: 16094564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of florfenicol and tulathromycin for the treatment of undifferentiated fever in Alberta feedlot calves.
    Van Donkersgoed J; Berg J; Hendrick S
    Vet Ther; 2008; 9(4):275-81. PubMed ID: 19177332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of tulathromycin in the treatment and prevention of natural outbreaks of bovine respiratory disease in European cattle.
    Godinho KS; Wolf RM; Sherington J; Rowan TG; Sunderland SJ; Evans NA
    Vet Ther; 2005; 6(2):122-35. PubMed ID: 16094560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effectiveness of tulathromycin, a novel triamilide antimicrobial, for the control of respiratory disease in cattle at high risk for developing bovine respiratory disease.
    Kilgore WR; Spensley MS; Sun F; Nutsch RG; Rooney KA; Skogerboe TL
    Vet Ther; 2005; 6(2):136-42. PubMed ID: 16094561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of tulathromycin or enrofloxacin for initial treatment of naturally occurring bovine respiratory disease in feeder calves.
    Robb EJ; Tucker CM; Corley L; Bryson WL; Rogers KC; Sturgess K; Bade DJ; Brodersen B
    Vet Ther; 2007; 8(2):127-35. PubMed ID: 17616947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of enrofloxacin to that of tulathromycin for the control of bovine respiratory disease and prevalence of antimicrobial resistance in Mannheimia haemolytica in calves at high risk of developing bovine respiratory disease.
    Crosby S; Credille B; Giguère S; Berghaus R
    J Anim Sci; 2018 Apr; 96(4):1259-1267. PubMed ID: 29471391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic efficacy of tulathromycin, a novel triamilide antimicrobial, against bovine respiratory disease in feeder calves.
    Kilgore WR; Spensley MS; Sun F; Nutsch RG; Rooney KA; Skogerboe TL
    Vet Ther; 2005; 6(2):143-53. PubMed ID: 16094562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of treatment of cattle with bovine respiratory disease with tulathromycin.
    Wellman NG; O'Connor AM
    J Vet Pharmacol Ther; 2007 Jun; 30(3):234-41. PubMed ID: 17472655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between antimicrobial drug class for treatment and retreatment of bovine respiratory disease (BRD) and frequency of resistant BRD pathogen isolation from veterinary diagnostic laboratory samples.
    Coetzee JF; Magstadt DR; Sidhu PK; Follett L; Schuler AM; Krull AC; Cooper VL; Engelken TJ; Kleinhenz MD; O'Connor AM
    PLoS One; 2019; 14(12):e0219104. PubMed ID: 31835273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limitations of bacterial culture, viral PCR, and tulathromycin susceptibility from upper respiratory tract samples in predicting clinical outcome of tulathromycin control or treatment of bovine respiratory disease in high-risk feeder heifers.
    Sarchet JJ; Pollreisz JP; Bechtol DT; Blanding MR; Saltman RL; Taube PC
    PLoS One; 2022; 17(2):e0247213. PubMed ID: 35143504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the cost implications of a radio frequency identification feeding system for early detection of bovine respiratory disease in feedlot cattle.
    Wolfger B; Manns BJ; Barkema HW; Schwartzkopf-Genswein KS; Dorin C; Orsel K
    Prev Vet Med; 2015 Mar; 118(4):285-92. PubMed ID: 25534973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of tulathromycin in the treatment of bovine respiratory disease associated with induced Mycoplasma bovis infections in young dairy calves.
    Godinho KS; Rae A; Windsor GD; Tilt N; Rowan TG; Sunderland SJ
    Vet Ther; 2005; 6(2):96-112. PubMed ID: 16094558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feedlot health and performance effects associated with the timing of respiratory disease treatment.
    Babcock AH; White BJ; Dritz SS; Thomson DU; Renter DG
    J Anim Sci; 2009 Jan; 87(1):314-27. PubMed ID: 18765846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Field study of the comparative efficacy of gamithromycin and tulathromycin for the control of undifferentiated bovine respiratory disease complex in beef feedlot calves at high risk of developing respiratory tract disease.
    Torres S; Thomson DU; Bello NM; Nosky BJ; Reinhardt CD
    Am J Vet Res; 2013 Jun; 74(6):839-46. PubMed ID: 23718651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.